Bayer Aktiengesellschaft (BAYN.DE) Stock

Healthcare · Drug Manufacturers - General · Member of DAX

Bayer Aktiengesellschaft (BAYN.DE) closed at EUR 45.07 on 2026-10-14, a change of +64.7 % over the past year, with a market capitalization of EUR 43.63B.

Bayer Aktiengesellschaft recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Bayer Aktiengesellschaft key figures

Previous close

EUR 45.07 (2026-10-14)

1-year change

+64.7 %

Market cap

EUR 43.63B

Enterprise value

EUR 77.1B

P/E ratio (trailing)

-24.67

P/E ratio (forward)

9.18

EPS (trailing)

-1.80

EPS (forward)

4.84

PEG ratio

4.65

Price to book

1.47

Revenue growth

1.2 %

Earnings growth

n/a

Dividend per share (trailing)

0.11

Short ratio

n/a

Employees

87,830

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. It has a commercial agreement with Neste to Jointly scale newgold winter canola for biofuels production. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Bayer Aktiengesellschaft and compare it with other stocks.